Development of novel biomarker for diagnosis of gastrointestinal cancer using liquid biopsy

Development of novel biomarker for diagnosis of gastrointestinal cancer using liquid biopsy - Development of novel biomarker for diagnosis of gastrointestinal cancer using liquid biopsy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033490

Enrollment

100

Registered

2018-09-01

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with gastrointestinal cancer (gastric cancer, colorectal cancer, esophageal cancer, gastrointestinal neuroendocrine tumor, pancreatic cancer, liver cancer), from which written informed consent was obtained.

Exclusion criteria

Exclusion criteria: Patients in which consent was not obtained.

Design outcomes

Primary

Measure	Time frame
Efficacy	—

Countries

Japan

Contacts

Public ContactYasushi Sato

Tokushima University Graduate School of Biomedical Sciences Department of Community Medicine for Gastroenterology and Oncology

yasushis2012@gmail.com088-633-7122

Outcome results